
Saso Cemerski
Senior Director at Cue Biopharma
Washington University
St. Louis
Biography
Saso Cemerski, Senior Director at Cue Biopharma, leads the company’s Immuno-Oncology Discovery and Translational Immunology team. His focus is on early pipeline development, building preclinical packages for IO assets and developing translational biomarker strategies to test key hypotheses in the clinic. Prior to joining Cue Biopharma, Dr. Cemerski held positions at Xencor, BMS and most recently, MSD where he led the STING agonist programs and was a core- team member of the anti-LAG-3 program, both currently in the clinic. Dr. Cemerski did his postdoctoral training at Washington University in St Louis working on elucidating how immune synapses control T cell activation.
Research Interest
Oncology & Translational Immunology